BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22897229)

  • 1. Recurrent menstrual toxic shock syndrome despite discontinuation of tampon use: is menstrual toxic shock syndrome really caused by tampons?
    Dixit S; Fischer G; Wittekind C
    Australas J Dermatol; 2013 Nov; 54(4):283-6. PubMed ID: 22897229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic shock syndrome of a probable gynecologic source in an adolescent: a case report and review of the literature.
    LeRiche T; Black AY; Fleming NA
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):e133-7. PubMed ID: 23095525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxic shock syndrome in a 14-year-old girl].
    Lüders D; Phieler H
    Monatsschr Kinderheilkd; 1984 Apr; 132(4):217-21. PubMed ID: 6727895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
    Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic shock syndrome consecutive to the presence of vaginal tampon for menstruation regressive after early haemodynamic optimization and activated protein C infusion].
    Ellies E; Vallée F; Mari A; Silva S; Bauriaud R; Fourcade O; Genestal M
    Ann Fr Anesth Reanim; 2009 Jan; 28(1):91-5. PubMed ID: 19108981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
    Shands KN; Schmid GP; Dan BB; Blum D; Guidotti RJ; Hargrett NT; Anderson RL; Hill DL; Broome CV; Band JD; Fraser DW
    N Engl J Med; 1980 Dec; 303(25):1436-42. PubMed ID: 7432402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus exotoxins are present in vivo in tampons.
    Schlievert PM; Nemeth KA; Davis CC; Peterson ML; Jones BE
    Clin Vaccine Immunol; 2010 May; 17(5):722-7. PubMed ID: 20335433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock syndrome.
    Tofte RW; Williams DN
    Postgrad Med; 1983 Jan; 73(1):275-80, 285-8. PubMed ID: 6336841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Menstrual toxic shock syndrome].
    Bertram H; Wilken M
    Klin Padiatr; 1993; 205(5):373-8. PubMed ID: 8411906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
    Petrás P; Machová I; Rysková L; Prásil P
    Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device-Associated Menstrual Toxic Shock Syndrome.
    Schlievert PM; Davis CC
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32461307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic shock syndrome and other tampon related risks.
    Cibulka NJ
    JOGN Nurs; 1983; 12(2):94-9. PubMed ID: 6551545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal toxic shock: two fulminant cases with recovery.
    Scobie BA
    N Z Med J; 1982 Mar; 95(703):145-7. PubMed ID: 6952124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
    Jacquemond I; Muggeo A; Lamblin G; Tristan A; Gillet Y; Bolze PA; Bes M; Gustave CA; Rasigade JP; Golfier F; Ferry T; Dubost A; Abrouk D; Barreto S; Prigent-Combaret C; Thioulouse J; Lina G; Muller D
    Sci Rep; 2018 Jul; 8(1):9942. PubMed ID: 29967393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic Shock Syndrome: Still a Timely Diagnosis.
    Gossack-Keenan KL; Kam AJ
    Pediatr Emerg Care; 2020 Mar; 36(3):e163-e165. PubMed ID: 29040243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.
    Davis JP; Chesney PJ; Wand PJ; LaVenture M
    N Engl J Med; 1980 Dec; 303(25):1429-35. PubMed ID: 7432401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development of toxic shock syndrome. Association with a tampon brand.
    Schlech WF; Shands KN; Reingold AL; Dan BB; Schmid GP; Hargrett NT; Hightower A; Herwaldt LA; Neill MA; Band JD; Bennett JV
    JAMA; 1982 Aug; 248(7):835-9. PubMed ID: 7097945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome and tampons.
    Schuchat A; Broome CV
    Epidemiol Rev; 1991; 13():99-112. PubMed ID: 1662639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
    Vischer WA; Stalder H; Faupel DM
    Schweiz Med Wochenschr; 1985 Aug; 115(35):1196-9. PubMed ID: 4048915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.